| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
29,153 |
22,210 |
$1.29M |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
7,422 |
6,700 |
$406K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
6,775 |
6,565 |
$203K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
2,565 |
2,517 |
$160K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
21,262 |
17,035 |
$143K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
2,115 |
2,074 |
$135K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
2,095 |
2,030 |
$121K |
| 87070 |
|
21,326 |
17,072 |
$87K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
979 |
966 |
$73K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
5,490 |
2,369 |
$66K |
| 69210 |
|
2,830 |
2,467 |
$49K |
| 90677 |
|
1,364 |
1,313 |
$38K |
| 99050 |
|
1,649 |
1,586 |
$35K |
| 3008F |
|
3,697 |
3,625 |
$31K |
| 90716 |
|
956 |
888 |
$23K |
| 99381 |
|
369 |
353 |
$23K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
795 |
773 |
$22K |
| 90686 |
|
3,577 |
3,412 |
$22K |
| 90619 |
|
556 |
539 |
$19K |
| 99188 |
|
714 |
700 |
$17K |
| 90621 |
|
331 |
319 |
$13K |
| 90707 |
|
962 |
890 |
$12K |
| 83655 |
|
774 |
731 |
$10K |
| 90680 |
|
1,412 |
1,303 |
$9K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
517 |
506 |
$7K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
83 |
83 |
$7K |
| 90700 |
|
2,126 |
1,968 |
$6K |
| 90633 |
|
1,008 |
933 |
$6K |
| 90715 |
|
371 |
358 |
$5K |
| 90713 |
|
1,615 |
1,483 |
$5K |
| 90670 |
|
653 |
629 |
$5K |
| 90696 |
|
430 |
394 |
$5K |
| 17110 |
|
108 |
104 |
$5K |
| 36415 |
Collection of venous blood by venipuncture |
516 |
500 |
$4K |
| 90744 |
|
1,465 |
1,365 |
$3K |
| 90651 |
|
39 |
36 |
$3K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
806 |
683 |
$3K |
| 36410 |
|
207 |
197 |
$3K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
30 |
30 |
$3K |
| 85018 |
|
1,890 |
1,811 |
$2K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
264 |
216 |
$2K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
126 |
120 |
$2K |
| 90648 |
|
2,117 |
1,950 |
$2K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
610 |
534 |
$2K |
| 51701 |
|
38 |
29 |
$1K |
| 81002 |
|
620 |
550 |
$924.47 |
| 17250 |
|
12 |
12 |
$365.98 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
20 |
17 |
$171.87 |
| 94664 |
|
14 |
12 |
$61.02 |
| 99173 |
|
21 |
21 |
$33.37 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
100 |
91 |
$4.20 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
20 |
17 |
$0.85 |